Store Facets Summary
Main page content
Published: May 2020
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Talk. They Hear You: Talking With Your Child About Opioids: Keeping Your Kids Safe - Parent Brochure
Published: June 2019
This brochure is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging parents to talk with their kids about the risks of misusing prescription pain medications and to have conversations with their kids to help them avoid taking medication that is not theirs.
Published: August 2018
This series of four fact sheets emphasizes the importance of continuing a mother's treatment for opioid use disorder (OUD) throughout pregnancy. The series includes information on OUD and pregnancy, OUD treatment, neonatal abstinence syndrome, and considerations to address before hospital discharge.